AI VIVO
3 known investors
Find your way into AI VIVO
393 people in our graph share verified history with the AI VIVO team — schools, employers, funds. One of them is your warm intro.
Sridhar Ramaswamyunlockedknows Peyman Gifani · together at University of Cambridge (overlapped)
×10knows the team · via University of Cambridge
knows the team · via Amirkabir University of Technology - Tehran Polytechnic
AIVIVO develops drug discovery solutions at the organism level, focusing on accelerating pharmaceutical development processes.
Founders & leadership
PG
Peyman GifaniinFounderHe brings expertise in systems pharmacology, systems biology, synthetic biology, nonlinear dynamics, and machine learning applications to pharmaceutical development.
Investors · 3
Companies House · registry record
View on Companies House ↗- Registered name
- AIVIVO LTD
- Company number
- 10694447
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 28 Mar 2017
- Registered office
- 25 Bioinnovation Centre, Cambridge Science Park, Milton, Cambridge, England, CB4 0FW
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology74909 — Other professional, scientific and technical activities n.e.c.
- Accounts
- last made up to 31 Mar 2026 · next due 31 Dec 2027
- Confirmation statement
- last made up to 27 Mar 2026 · next due 10 Apr 2027
Current officers · 3
- Matthew Gregory Richard Cleevely — director, appointed 10 Oct 2019
- Peyman Gifani — director, appointed 28 Mar 2017
- Mehdi Shahidi — director, appointed 29 Oct 2019
Source: Companies House public register · retrieved 3 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does AI VIVO do?
- AIVIVO develops drug discovery solutions at the organism level, focusing on accelerating pharmaceutical development processes.
- Who founded AI VIVO?
- AI VIVO was founded by Peyman Gifani.
- Who are AI VIVO's investors?
- AI VIVO's investors include EMV Capital, Manta Ray Ventures, Martlet Capital.